IMPLEMENTATION OF SCIENTIFIC COSTING IN BULK DRUG AND R&D DEPARTMENT OF A PHARMA INDUSTRY Submitted By KAUSTUBH NIJASURE Under the guidance of Prof. P.M. Nayak A PROJECT SUBMITTED IN PART COMPLETITION OF MMS TO THE Vidyalankar Institute Of Technology Wadala (East)‚ Mumbai 400 031 JULY 14th‚ 2008 Executive summary: Centaur Pharmaceuticals Pvt. Ltd. has following divisions: 1. Bulk Drug 2. Formulations 3. Research and Development 4. Clinical Research
Premium Costs Cost Pharmacology
efficient portfolio------------------------------------------------------------------------------------- | 09-19 | LETTER OF TRANSMITTAL P LETTER OF TRANSMITTAL P November 22‚ 2012 Pallabi Siddiqua Assistant Professor Department of Finance University of Dhaka Dhaka Dear Madam‚ It is an honor and great pleasure for me to present my report on “Efficient Portfolio Construction”
Premium Stock market Investment Finance
Employee Portfolio: Management Plan Bonejean Jordan MGT/311 September 30‚ 2013 Steven Spencer University of Phoenix Material Employee Portfolio Complete one matrix for each employee. Employee name: Larissa Self Assessment Results Summary Strengths Weaknesses How Satisfied Am I with My Job? Studies using this instrument tend to find means in the 74 to 76 range. If you scored low‚ you might want to look at specific items in this questionnaire. Are there certain aspects of
Premium Emotion Decision making
growing rapidly due to the capability of Indian players to produce cost-effective drugs with world class manufacturing facilities. Bulk drugs of all major therapeutic groups‚ requiring complicated manufacturing processes are now being produced in India. Pharma companies have developed Good Manufacturing Practices (GMP) compliant facilities for the production of different dosage forms. In addition‚ India’s long-established position as a preferred manufacturing location for multinational drug manufacturers
Premium Pharmaceutical industry Clinical trial Pharmacology
2012104045 PROJECT METHODOLOGY I. Summary Project methodology is a project or study that could help manage the works of people and develop the creativity and imagination of the children. It is like a list of step by step process in every work‚ consisting of designs and plans that could help in making the project or work executable or manageable. Every details of the project are listed starting from the beginning up to until the end of the project. II. Opinion In my opinion‚ having a project methodology
Premium Project management Creativity Epistemology
Pinteroffice memorandum to: | tANIA pARKER | from: | MOHAMMED ZOAHEB | subject: | ms project part 2 | date: | June 14‚ 2013 | cc: | [Name] | | | 1. Which if any of the resources are over allocated? * Marketing staff * R&D * Legal staff 2. Assume that the project is time constrained and try to resolve any over allocation problems by leveling within slack. What happens? The Marketing staff and legal staff over allocated problem is solved‚ however R&D cannot
Premium Critical path method Project management Resource allocation
Project ManagementTop Down/Bottom Up methods Consensus methods Snr/middle managers’ guess total project time & cost Discussing/arguing to reach a decision on best guestimates Firms seeking greater precision: Delphi Method: Group decision process of chance of certain events occurring Exp. familiar with project use insight/exp. guessing project costs/times Ratio methods Macro methods use ratios to guess time & cost E.g. contractors using no. of sq. ft. to guess cost/time to build
Premium Ratio Learning curve Project management
(EST) Early start Time is the earliest time the activity can begin. (LST) Late start Time is the latest time the activity can begin and still allow the project to be completed on time. (EFT) Early finish Time is the earliest time the activity can end. (LFT) Late finish Time is the latest time the activity can end and still allow the project to be completed on time Diagram A: Activity-on-the-node diagram Timing of activities in the network diagram is determined by the following calculations
Premium Project management Critical path method
Scope of this report: The scope of the report was based on the annual reports & web site‚ input from interviews of executives of the SQUARE Pharmaceuticals Limited. To analyze the situation in question‚ we worked on focusing on SQUARE Pharmaceuticals Limited and analyzing their objectives‚ market strategies‚ market situations‚ product mixes‚ etc. The analysis was based on the exposed and available information only. In-depth data were not always available on-demand due to some unavailable reasons
Premium Marketing Pharmaceutical industry Pharmacology
researchandmarkets.com/reports/680564/ The Top Five Global Pharma Companies; Where they are Now and Where they heading? Description: A mini report identifying drivers and barriers to sustaining financial performance over the next 5 years for the top five global pharmaceutical companies -Johnson & Johnson‚ Pfizer‚ GSK‚ Novartis and Sanofi-Aventis This report presents the cases of the top five global pharma companies: J&J‚ Pfizer‚ GSK‚ Novartis and Sanofi-Aventis and identifies their key growth areas
Premium Pharmaceutical industry Credit card P/E ratio